Guido J Neels's Net Worth

$4.31 Million

Estimate Recalculated Sep 17, 2024 08:17PM EST

Who is Guido J Neels

Guido J Neels has an estimated net worth of $4.31 Million. This is based on reported shares across multiple companies, which include ENTELLUS MEDICAL INC, Bioventus Inc., LEMAITRE VASCULAR INC, Axogen, Inc., ENDOLOGIX INC /DE/, BIOPURE CORP, and GUIDANT CORP.

SEC CIK

Guido J Neels's CIK is 0001222362

Past Insider Trading and Trends

2021 was Guido J Neels's most active year for acquiring shares with 9 total transactions. Guido J Neels's most active month to acquire stocks was the month of May. 2005 was Guido J Neels's most active year for disposing of shares, totalling 5 transactions. Guido J Neels's most active month to dispose stocks was the month of January. 2005 saw Guido J Neels paying a total of $673,800.00 for 101,500 shares, this is the most they've acquired in one year. In 2005 Guido J Neels cashed out on 120,000 shares for a total of $4,381,279.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ENTELLUS MEDICAL INC

Investor
Updated Mar 01, 2018
Form 4
-100.00%
-47.50K
$16.84
-$720.10K
Mar 01, 2018
Disposition
Feb 28
Form 4
50.00%
7.50K
Jun 14, 2017
22.50K
Grant
Jun 13
Form 4
10.00K
Jun 15, 2016
25.00K
Grant
Jun 14
Form 4
15.00K
$17.00
$255.00K
Feb 04, 2015
15.00K
Purchase
Feb 03
Form 3
Jan 28, 2015
Showing 5 results

Bioventus Inc.

Investor
Updated Jun 13, 2024
Form 4
26.49K
Jun 13, 2024
26.49K
Grant
Jun 11
Form 4
Jun 11, 2024
58.75K
Options
Jun 07
Form 4
107.24%
30.40K
Jun 08, 2023
58.75K
Options
Jun 06 - Jun 07
Form 4
16.65K
Jun 22, 2022
16.65K
Grant
Jun 17
Form 4
Apr 05, 2022
11.70K
Options
Apr 01
Form 4
Feb 15, 2022
9.00K
Options
Feb 11
Form 4
2.70K
Apr 05, 2021
2.70K
Grant
Apr 01
Form 4
9.00K
Feb 16, 2021
9.00K
Grant
Feb 11
Form 3
Feb 11, 2021
Showing 9 results

LEMAITRE VASCULAR INC

Investor
Updated Dec 22, 2006
Form 4
2.81K
Dec 22, 2006
2.81K
Grant
Dec 22
Form 3
Oct 18, 2006
Showing 2 results

Axogen, Inc.

Investor
Updated Sep 04, 2024
Form 4
Sep 04, 2024
90.82K
Options
Sep 01
Form 4
42.34%
28.90K
Jun 10, 2024
97.16K
Grant
Jun 06
Form 4
32.34K
Sep 07, 2023
32.34K
Grant
Sep 01
Form 4
17.16%
10.00K
$6.11
$61.10K
Aug 18, 2023
68.26K
Purchase
Aug 16
Form 4
Jun 05, 2023
58.26K
Options
Jun 01
Form 4
35.27%
18.27K
Jun 03, 2022
70.07K
Options
Jun 01
Form 4/A
$4.37
Jun 07, 2021
42.59K
Options
May 19
Form 4
18.59%
9.07K
Jun 03, 2021
57.83K
Options
Jun 01
Form 4
$4.37
May 21, 2021
42.59K
Options
May 19
Form 4
2.59K
$11.75
$30.44K
Sep 08, 2020
2.59K
Grant
Sep 03
Form 4/A
18.78K
Jun 12, 2020
18.78K
Grant
Jun 01
Form 4
20.92K
Jun 03, 2020
20.92K
Grant
Jun 01
Form 4
13.30K
Sep 05, 2019
13.30K
Grant
Sep 03
Form 4
4.78K
Jun 05, 2018
4.78K
Grant
Jun 01
Form 4
-25.44%
-1.15M
$19.74
-$22.70M
Nov 21, 2017
3.37M
Sale
Nov 20
Form 4
15.00K
Jun 08, 2017
15.00K
Grant
Jun 01
Form 4
5.00K
Jan 03, 2017
5.00K
Grant
Dec 29
Form 4/A
15.00K
May 31, 2016
15.00K
Grant
Dec 28
Form 4
15.00K
Dec 30, 2015
15.00K
Grant
Dec 28
Form 3
Sep 02, 2015
4.86M
Showing 20 results

ENDOLOGIX INC /DE/

Investor
Updated Apr 03, 2019
Form 4
110.65%
22.69K
$6.61
$149.99K
Apr 03, 2019
43.20K
Purchase
Apr 03
Form 4
143.57%
120.89K
Jan 03, 2019
205.09K
Grant
Dec 30
Form 4
37.18%
22.82K
Jun 02, 2017
84.20K
Grant
May 31
Form 4
48.33%
20.00K
$4.32
$86.40K
May 23, 2017
61.38K
Purchase
May 19
Form 4
45.81%
13.00K
$7.69
$99.97K
Nov 22, 2016
41.38K
Purchase
Nov 18
Form 4
36.95%
7.66K
Jun 06, 2016
28.38K
Grant
Jun 02
Form 4
40.66%
11.00K
$9.32
$102.52K
Nov 03, 2015
38.06K
Purchase
Nov 03
Form 4
6.03K
Jun 01, 2015
6.03K
Grant
May 28
Form 4/A
106.91%
7.59K
Feb 18, 2015
14.70K
Grant
May 22
Form 4
58.63%
10.00K
$11.21
$112.10K
Nov 05, 2014
27.06K
Purchase
Nov 04
Form 4
31.43%
7.59K
May 27, 2014
31.75K
Grant
May 22
Form 4
41.64%
7.10K
$14.08
$100.00K
May 25, 2012
24.16K
Grant
May 24
Form 4
50.00K
Dec 20, 2011
50.00K
Grant
Dec 15
Form 4
17.05K
$5.92
$101.02K
Mar 02, 2011
17.06K
Purchase
Feb 28
Form 3
Dec 14, 2010
Showing 15 results

BIOPURE CORP

Investor
Updated Sep 16, 2008
Form 4
707.55%
75.00K
$0.33
$24.75K
Sep 16, 2008
85.60K
Grant
Sep 15
Form 4
58.82%
10.00K
$0.79
$7.90K
Nov 06, 2007
27.00K
Purchase
Nov 01
Form 4
$0.55
Jul 19, 2007
70.00K
Purchase
Jul 18
Form 4
52.63%
20.00K
$0.55
$11.00K
Apr 05, 2007
58.00K
Grant
Apr 04
Form 4
92.31%
24.00K
$0.92
$22.08K
May 24, 2006
50.00K
Options
May 23
Form 4
66.67%
20.00K
$1.34
$26.80K
Mar 24, 2006
50.00K
Grant
Mar 22
Form 4
30.00K
$0.92
$27.60K
Oct 14, 2005
30.00K
Grant
Oct 13
Showing 7 results

GUIDANT CORP

Chief Operating Officer
Updated Jun 03, 2005
Form 4
6.24%
11.50K
Jun 03, 2005
211.73K
Grant
Jun 01
Form 4
-24.60%
-60.00K
$41.90
-$3.74M
Feb 10, 2005
199.73K
Sale
Feb 08
Form 4
$7.88
$637.93K
Aug 13, 2004
199.46K
Options
Aug 11
Form 4
21.75%
21.00K
May 18, 2004
118.08K
Grant
May 17
Form 4
55.83%
50.95K
Apr 05, 2004
142.73K
Grant
Apr 01
Form 4
-2.15%
-2.00K
$15.43
-$101.61K
Nov 07, 2003
91.71K
Sale
Nov 05
Showing 6 results